search
Back to results

Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management

Primary Purpose

Renal Colic, Urinary Calculi

Status
Completed
Phase
Phase 4
Locations
Qatar
Study Type
Interventional
Intervention
Diclofenac
Morphine
Paracetamol
Placebos
Sponsored by
Hamad Medical Corporation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Renal Colic focused on measuring Acute Renal colic, Acute Ureteric Colic, Renal or Ureteral Calculi, Urolithiasis, Kidney or Ureteral stones

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age >=18 years and < 65 years
  • Acute onset, one side flank or loin pain, with or without radiation to groin or genital areas.
  • Pain intensity on NRS more than or equal to 4. (Moderate to Severe Pain)
  • Diagnosis confirmed by non contrast CT KUB within the ED visit.

Exclusion Criteria:

  • Traumatic flank pain
  • Pregnancy
  • Known renal failure or impairment
  • Known allergy to morphine, diclofenac or paracetamol
  • Bronchial asthma
  • Previously enrolled in the study.
  • Use of any analgesia in last 6 hour.

Sites / Locations

  • Emergency Department, Hamad General Hospital.

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Active Comparator

Arm Label

Diclofenac and Placebos

Morphine and Placebos

Paracetamol and Placebos

Arm Description

Participants in this group will receive a Diclofenac 75 mg intramuscular injection, and two placebo saline solutions intravenously.

Participants in this group will receive Morphine 0.1 mg/kg intravenously, along with an additional intravenous placebo and an intramuscular placebo injection.

participants in this group will receive intravenous Paracetamol 1 gm solution, along with an additional intravenous placebo and an intramuscular placebo injection.

Outcomes

Primary Outcome Measures

The proportion of patients achieving a reduction of >50% on Numerical Rating Scale (NRS-11) from the initial NRS recorded at the end of 30 minutes in each study arm.

Secondary Outcome Measures

reduction in mean NRS

Full Information

First Posted
July 7, 2014
Last Updated
March 17, 2015
Sponsor
Hamad Medical Corporation
search

1. Study Identification

Unique Protocol Identification Number
NCT02187614
Brief Title
Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management
Official Title
A Double Blind, Multi-arm Randomized Control Trial, for Efficacy of Intramuscular Diclofenac Versus Intravenous Morphine Versus Intravenous Paracetamol, in Renal Colic Emergency Department Pain Management
Study Type
Interventional

2. Study Status

Record Verification Date
March 2015
Overall Recruitment Status
Completed
Study Start Date
August 2014 (undefined)
Primary Completion Date
February 2015 (Actual)
Study Completion Date
March 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hamad Medical Corporation

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Abdominal pain is one of the most common presentations to an emergency department (ED). Among patients presenting with abdominal pain, a common diagnosis in the Middle East is renal colic (urolithiasis or Kidney stones). As the patients with renal colic writhe around in agonizing pain, the first priority in an ED from a patient's perspective is fast and safe analgesia and to be pain free as early as possible. There are variations in physician preference to choose initial analgesic drug for managing such pain. Commonly used drugs are: Opioids such as Morphine or Fentanyl Non steroidal drugs such as Diclofenac, Ketorolac or Brufen and Paracetamol intravenous injection. A robust evidence in comparison of diclofenac versus morphine and paracetamol is lacking. This study is design to obtain data on efficacy of these three drugs within 30 minutes in a non inferiority trail.
Detailed Description
This will be a double blind RCT, where participants will be enrolled consecutively after meeting eligibility criteria and obtaining a written informed consent. They will be assign to one of the three study arms by computer generated randomization process. The study packets will be prepared by a dedicated nurse or pharmacist who will not a part of investigating team. Each Patients will receive one analgesic drug (active drug) and two placebos. Drugs will be given as one intramuscular injection and two intravenous solutions. Pain score will be recorded using NRS at 0, 30, 60, and 90 minutes. Data will be collected on standard Data collection form. Each participant will receive analgesia from study packet which contains, one active drug and two placebos to be administer as one intramuscular and two intravenous solutions. At any given time every patient will receive one analgesia from either Diclofenac, Paracetamol or Morphine. If patient pain does not respond to initial treatments, at 30 minutes a rescue analgesia in form of morphine will be administered till patient is pain free or NRS<=2 or adverse event to morphine. Based on the results of previous studies (1-3), proportion of patients achieving more than 50% pain reduction, is between 65-75% for diclofenac, morphine and paracetamol when compared with other drugs. In each group, 437 patients are required to detect a difference of 10% in primary outcome, in a superiority trial with power (1-beta) of 90% and significance level (alpha) of 5% in this study. Considering 15% extra, total sample size required in this superiority trial will be 1507 patients in total. Data will be collected on a standard data recording form and it will be converted to electronic excel sheet hiding patient identifiable details. Continuous variables will be presented as mean with standard deviation (SD). Categorical variables will be calculated as proportions and presented with 95% Confidence interval (CI). Statistical analyses will be undertaken using Stata 12.0 (College Station, Texas).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Renal Colic, Urinary Calculi
Keywords
Acute Renal colic, Acute Ureteric Colic, Renal or Ureteral Calculi, Urolithiasis, Kidney or Ureteral stones

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
1645 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Diclofenac and Placebos
Arm Type
Experimental
Arm Description
Participants in this group will receive a Diclofenac 75 mg intramuscular injection, and two placebo saline solutions intravenously.
Arm Title
Morphine and Placebos
Arm Type
Active Comparator
Arm Description
Participants in this group will receive Morphine 0.1 mg/kg intravenously, along with an additional intravenous placebo and an intramuscular placebo injection.
Arm Title
Paracetamol and Placebos
Arm Type
Active Comparator
Arm Description
participants in this group will receive intravenous Paracetamol 1 gm solution, along with an additional intravenous placebo and an intramuscular placebo injection.
Intervention Type
Drug
Intervention Name(s)
Diclofenac
Other Intervention Name(s)
Voltaren, Diclofen, Diclorex
Intervention Type
Drug
Intervention Name(s)
Morphine
Other Intervention Name(s)
Morphine sulphate
Intervention Type
Drug
Intervention Name(s)
Paracetamol
Other Intervention Name(s)
Perfalgan, Acetaminophen
Intervention Type
Drug
Intervention Name(s)
Placebos
Other Intervention Name(s)
saline solution
Primary Outcome Measure Information:
Title
The proportion of patients achieving a reduction of >50% on Numerical Rating Scale (NRS-11) from the initial NRS recorded at the end of 30 minutes in each study arm.
Time Frame
at 30 minutes after analgesia
Secondary Outcome Measure Information:
Title
reduction in mean NRS
Time Frame
at 30, 60 and 90 minutes after analgesia
Other Pre-specified Outcome Measures:
Title
adverse event rate
Time Frame
Within 14 days of ED visit
Title
total analgesia requirement to get pain score (NRS) less than or equal to 2.
Time Frame
by 90 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age >=18 years and < 65 years Acute onset, one side flank or loin pain, with or without radiation to groin or genital areas. Pain intensity on NRS more than or equal to 4. (Moderate to Severe Pain) Diagnosis confirmed by non contrast CT KUB within the ED visit. Exclusion Criteria: Traumatic flank pain Pregnancy Known renal failure or impairment Known allergy to morphine, diclofenac or paracetamol Bronchial asthma Previously enrolled in the study. Use of any analgesia in last 6 hour.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dr.Sameer A. Pathan, MBBS, MCEM
Organizational Affiliation
Hamad Medical Corporation
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Prof. Peter A Cameron, MD,FACEM
Organizational Affiliation
Hamad Medical Corporation
Official's Role
Principal Investigator
Facility Information:
Facility Name
Emergency Department, Hamad General Hospital.
City
Doha
ZIP/Postal Code
3050
Country
Qatar

12. IPD Sharing Statement

Citations:
PubMed Identifier
20934829
Citation
Grissa MH, Claessens YE, Bouida W, Boubaker H, Boudhib L, Kerkeni W, Boukef R, Nouira S. Paracetamol vs piroxicam to relieve pain in renal colic. Results of a randomized controlled trial. Am J Emerg Med. 2011 Feb;29(2):203-6. doi: 10.1016/j.ajem.2009.09.019. Epub 2010 Oct 8.
Results Reference
background
PubMed Identifier
24350118
Citation
Behzadnia MJ, Javadzadeh HR, Saboori F. Time of admission, gender and age: challenging factors in emergency renal colic - a preliminary study. Trauma Mon. 2012 Fall;17(3):329-32. doi: 10.5812/traumamon.6800. Epub 2012 Oct 10.
Results Reference
background
Citation
Shaden Salameh; Nurit Hiller; Meir Antopolsky; Fedaa Ghanem; Yigaal Abramovitz; Ruth Stalnikowics. Diclofenac versus Tramadol in the Treatment of Renal Colic: A Prospective, Randomized Trial. The Open Emergency Medicine Journal. 2011; 4: 9-13.
Results Reference
background
PubMed Identifier
26993881
Citation
Pathan SA, Mitra B, Straney LD, Afzal MS, Anjum S, Shukla D, Morley K, Al Hilli SA, Al Rumaihi K, Thomas SH, Cameron PA. Delivering safe and effective analgesia for management of renal colic in the emergency department: a double-blind, multigroup, randomised controlled trial. Lancet. 2016 May 14;387(10032):1999-2007. doi: 10.1016/S0140-6736(16)00652-8. Epub 2016 Mar 16.
Results Reference
derived

Learn more about this trial

Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management

We'll reach out to this number within 24 hrs